The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Effect of organised cervical cancer screening on cervical cancer mortality in Europe: a systematic review
Open accessAbstract
BACKGROUND: Organised cervical cancer (CC) screening programmes are delivered in many different ways across the European Union and its regions. Our aim was to systematically review the impact of these programs on CC mortality. METHODS: Two independent reviewers identified all eligible studies investigating the effect of organised screening on CC mortality in Europe. Six databases including Embase, Medline and Web of Science were searched (March 2018) with predefined inclusion and exclusion criteria. Only original studies with at least five years of follow-up were considered. Validated tools were used to assess the risk of bias of the included studies. RESULTS: Ten observational studies were included: seven cohort and three case-control studies. No randomised controlled trials were found, and there were no eligible studies from the eastern and southern part of Europe. Among the eligible studies, seven were conducted in the twentieth century; they scored lower on the risk of bias assessment. CC mortality reduction for women attending organised screening vs. non-attenders ranged from 41% to 92% in seven studies. Reductions were similar in Western (45-92%) and Northern (41-87%) Europe and were higher in the three more recent studies (66-92%). For invited vs. non-invited women, this reduction ranged from 17% to 79% in five studies. CONCLUSION: Although data were lacking in Southern and Eastern Europe and the effect size varied between countries and studies, this systematic review provides evidence that organised CC screening reduces CC mortality in those parts of Europe where CC screening was implemented and monitored.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
(2014) · Medical Entomology and Zoology · Cited by 17,633
Cancer Incidence in Five Continents
(1970) · Springer eBooks · doi:10.1007/978-3-642-85851-2 · Cited by 8,501
Zhang, J., & Yu, K. F. (1998) · JAMA · doi:10.1001/jama.280.19.1690 · Cited by 4,138
Arbyn, M., Anttila, A., Jordan, J., Ronco, G., Schenck, U., Segnan, N., Wiener, H., Herbert, A., & von Karsa, L. (2010) · Annals of Oncology · doi:10.1093/annonc/mdp471 · Cited by 760
Self-citationvon Karsa, L., Anttila, A., Ronco, G., Ponti, A., Malila, N. K., Arbyn, M., Segnan, N., Castillo-Beltran, M., Boniol, M., Ferlay, J., et al. (2008) · Cited by 551
Self-citationRijkaart, D. C., Berkhof, J., Rozendaal, L., van Kemenade, F. J., Bulkmans, N. W., Heideman, D. A., Kenter, G. G., Cuzick, J., Snijders, P. J., & Meijer, C. J. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70296-0 · Cited by 515
Screening for cervical cancer: a systematic review and meta-analysis
Peirson, L., Fitzpatrick-Lewis, D., Ciliska, D., & Warren, R. (2013) · Systematic Reviews · doi:10.1186/2046-4053-2-35 · Cited by 431
Sasieni, P., Castanon, A., & Cuzick, J. (2009) · BMJ · doi:10.1136/bmj.b2968 · Cited by 399
Landy, R., Pesola, F., Castañón, A., & Sasieni, P. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.290 · Cited by 379
Screening-Preventable Cervical Cancer Risks: Evidence From a Nationwide Audit in Sweden
Andrae, B., Kemetli, L., Sparen, P., Silfverdal, L., Strander, B., Ryd, W., Dillner, J., & Tornberg, S. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn099 · Cited by 363
Threats to Applicability of Randomised Trials: Exclusions and Selective Participation
Britton, A., McKee, M., Black, N., McPherson, K., Sanderson, C., & Bain, C. (1999) · Journal of Health Services Research & Policy · doi:10.1177/135581969900400210 · Cited by 299
Self-citationBasu, P., Ponti, A., Anttila, A., Ronco, G., Senore, C., Vale, D. B., Segnan, N., Tomatis, M., Soerjomataram, I., Primic Žakelj, M., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31043 · Cited by 251
Self-citationTrends in cancer of the cervix uteri in Sweden following cytological screening
Bergström, R., Sparén, P., & Adami, H.-O. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690666 · Cited by 220
Screening and cervical cancer cure: population based cohort study
Andrae, B., Andersson, T. M.-L., Lambert, P. C., Kemetli, L., Silfverdal, L., Strander, B., Ryd, W., Dillner, J., Tornberg, S., & Sparen, P. (2012) · BMJ · doi:10.1136/bmj.e900 · Cited by 208
Elmunzer, B. J., Hayward, R. A., Schoenfeld, P. S., Saini, S. D., Deshpande, A., & Waljee, A. K. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001352 · Cited by 206
Cervical cancer screening in Europe: Quality assurance and organisation of programmes
Elfström, K. M., Arnheim-Dahlström, L., von Karsa, L., & Dillner, J. (2015) · European Journal of Cancer · doi:10.1016/j.ejca.2015.03.008 · Cited by 176
Kitchener, H. C., Gilham, C., Sargent, A., Bailey, A., Albrow, R., Roberts, C., Desai, M., Mather, J., Turner, A., Moss, S., et al. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.01.008 · Cited by 174
Arbyn, M., Rebolj, M., De Kok, I. M. C. M., Fender, M., Becker, N., O’Reilly, M., & Andrae, B. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.07.016 · Cited by 167
Self-citationOrganised vs. spontaneous pap-smear screening for cervical cancer: A case-control study
Nieminen, P., Kallio, M., Anttila, A., & Hakama, M. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990924)83:1<55::aid-ijc11>3.0.co;2-u · Cited by 159
Self-citationMacgregor, J. E., Campbello, M. K., Mann, E. M. F., & Swanson, K. (1994) · BMJ · doi:10.1136/bmj.308.6941.1407 · Cited by 139
van Ballegooijen, M., Marle, M. E. V. D. A., Patnick, J., Lynge, E., Arbyn, M., Anttila, A., Ronco, G., Dik, J.-W. H., & Habbema, F. (2000) · European Journal of Cancer · doi:10.1016/s0959-8049(00)00330-0 · Cited by 118
Self-citationPersoskie, A., & Ferrer, R. A. (2016) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2016.07.030 · Cited by 114
de Kok, I. M. C. M., van Rosmalen, J., Dillner, J., Arbyn, M., Sasieni, P. D., Iftner, T., & van Ballegooijen, M. (2012) · BMJ · doi:10.1136/bmj.e670 · Cited by 101
Vaccarella, S., Franceschi, S., Zaridze, D. G., Poljak, M., Veerus, P., Plummer, M., & Bray, F. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30275-3 · Cited by 90
Self-citationPap smear screening and changes in cervical cancer mortality in Sweden
Mählck, C. ‐., Jönsson, H., & Lenner, P. (1994) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(94)90177-5 · Cited by 87
Age-Specific Effectiveness of the Finnish Cervical Cancer Screening Programme
Lönnberg, S., Anttila, A., Luostarinen, T., et al. (2012) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-12-0162 · Cited by 72
Self-citationPapanicolaou Smear Screening and Cervical Cancer
Stenkvist, B. (1984) · JAMA · doi:10.1001/jama.1984.03350110023023 · Cited by 69
Isidean, S. D., Mayrand, M., Ramanakumar, A. V., Gilbert, L., Reid, S. L., Rodrigues, I., Ferenczy, A. S., Ratnam, S., Coutlée, F., Franco, E. L., et al. (2016) · International Journal of Cancer · doi:10.1002/ijc.30385 · Cited by 69
Harms of cervical cancer screening in the United States and the Netherlands
Habbema, D., Weinmann, S. A., Arbyn, M., Kamineni, A., Williams, A. E., de Kok, I. M. C. M., van Kemenade, F. J., Field, T. S., van Rosmalen, J., & Brown, M. L. (2016) · International Journal of Cancer · doi:10.1002/ijc.30524 · Cited by 67
Anttila, A., Lönnberg, S., Ponti, A., Suonio, E., Villain, P., Coebergh, J. W. W., & von Karsa, L. (2014) · European Journal of Cancer · doi:10.1016/j.ejca.2014.10.022 · Cited by 62
Self-citationEffect of organized screening on incidence and mortality of cervical cancer in Denmark.
Lynge, E., Madsen, M., & Engholm, G. (1989) · PubMed · Cited by 59
Mortality audit of the Finnish cervical cancer screening program
Lönnberg, S., Nieminen, P., Luostarinen, T., & Anttila, A. (2012) · International Journal of Cancer · doi:10.1002/ijc.27844 · Cited by 53
Self-citationChanges in cervical cancer incidence following the introduction of organized screening in Italy
Serraino, D., Gini, A., Taborelli, M., Ronco, G., Rossi, P. G., Zappa, M., Crocetti, E., Franzo, A., Falcini, F., Visioli, C. B., et al. (2015) · Preventive Medicine · doi:10.1016/j.ypmed.2015.01.034 · Cited by 43
Self-citationthe Turin Cervical Screening Working Group, Ronco, G., Pilutti, S., Patriarca, S., Montanari, G., Ghiringhello, B., Volante, R., Giordano, L., Zanetti, R., Mancini, E., et al. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602705 · Cited by 41
Self-citationObservational Studies in the Era of Randomized Trials
Castillo, R. C., Scharfstein, D. O., & MacKenzie, E. J. (2012) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.l.00242 · Cited by 36
Mortality of non‐participants in cervical screening: Register‐based cohort study
Dugué, P., Lynge, E., & Rebolj, M. (2013) · International Journal of Cancer · doi:10.1002/ijc.28586 · Cited by 35
Rozemeijer, K., Naber, S. K., Penning, C., Overbeek, L. I. H., Looman, C. W. N., de Kok, I. M. C. M., Matthijsse, S. M., Rebolj, M., van Kemenade, F. J., & van Ballegooijen, M. (2017) · BMJ · doi:10.1136/bmj.j504 · Cited by 33
Capocaccia, R., Martina, L., Inghelmann, R., Crocetti, E., Lisi, V. D., Falcini, F., Guzzinati, S., Rosso, S., Tagliabue, G., Tumino, R., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.24033 · Cited by 29
Early cervical neoplasia: advances in screening and treatment modalities.
Tierney, B. J., Westin, S. N., Schlumbrecht, M. P., & Ramirez, P. T. (2010) · PubMed · Cited by 10
Improving adherence to prescribed drugs
Neto, A. C. D. A., Aslani, P., & Chen, T. F. (2009) · BMJ · doi:10.1136/bmj.b3282 · Cited by 9
Cited by
The importance of long-term follow up of participants in clinical trials
Cuzick, J. (2023) · British Journal of Cancer · doi:10.1038/s41416-022-02038-4 · Cited by 101
Cervical cancer screening invitations in low and middle income countries: Evidence from Armenia
Antinyan, A., Bertoni, M., & Corazzini, L. (2021) · Social Science & Medicine · doi:10.1016/j.socscimed.2021.113739 · Cited by 18
An overview of factors influencing cancer screening uptake in primary healthcare institutions
Prusaczyk, A., Żuk, P., Guzek, M., Bogdan, M., Nitsch-Osuch, A., Oberska, J., & Karczmarz, S. (2022) · Family Medicine & Primary Care Review · doi:10.5114/fmpcr.2022.113019 · Cited by 3
Metadata
- Authors
- Jansen, E. E. L., Zielonke, N., Gini, A., Anttila, A., Segnan, N., Vokó, Z., Ivanuš, U., McKee, M., de Koning, H. J., de Kok, I. M. C. M., Veerus, P., Anttila, A., Heinävaara, S., Sarkeala, T., Csanádi, M., Pitter, J., Széles, G., Vokó, Z., Minozzi, S., Segnan, N., Senore, C., van Ballegooijen, M., Driesprong - de Kok, I., Gini, A., Heijnsdijk, E., Jansen, E., de Koning, H., Lansdorp – Vogelaar, I., van Ravesteyn, N., Zielonke, N., Ivanus, U., Jarm, K., Mlakar, D. N., Primic-Žakelj, M., McKee, M., & Priaulx, J.
- Venue
- European Journal of Cancer
- Publisher
- Elsevier BV
- Published
- 2020-03
- Volume
- 127
- Pages
- 207-223
- ISSN
- 0959-8049 (ISSN-L)
- OpenAlex
- W3001464222
- Cited by
- 258
- References
- 44
- FWCI
- 6.28
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.